Phio Pharmaceuticals Corp (PHIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,984 | 14,929 | 3,631 | 12,956 | 5,167 |
| Marketable Securities | N/A | N/A | N/A | N/A | 5,500 |
| TOTAL | $7,300 | $15,150 | $3,832 | $13,106 | $10,978 |
| Non-Current Assets | |||||
| PPE Net | 210 | 172 | 248 | 114 | 163 |
| Other Non-Current Assets | 529 | 0 | 18 | 177 | 18 |
| TOTAL | $739 | $172 | $266 | $291 | $181 |
| Total Assets | $8,039 | $15,322 | $4,098 | $13,397 | $11,159 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 809 | 550 | 511 | 917 | 1,163 |
| Accrued Expenses | 964 | 1,194 | 1,754 | 1,625 | 1,106 |
| TOTAL | $1,880 | $1,744 | $2,265 | $2,542 | $2,269 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 411 | 0 | 0 | 0 | 0 |
| TOTAL | $411 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $2,291 | $1,744 | $2,265 | $2,542 | $2,269 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 27 | 4 | 0 | 0 | 65,349 |
| Common Shares | 1 | N/A | N/A | N/A | 1 |
| Retained earnings | -94,819 | -85,911 | -78,551 | -66,099 | -57,105 |
| Other shareholders' equity | 0 | 0 | 0 | 3,525 | 0 |
| TOTAL | $5,748 | $13,578 | $1,833 | $10,855 | $8,890 |
| Total Liabilities And Equity | $8,039 | $15,322 | $4,098 | $13,397 | $11,159 |